Liliane Fossati‐Jimack

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression

Daniel A. Mitchell, Matthew C. Pickering, Joanna Warren et al. · The Journal of Immunology · 2002 · 228 citations · Full text

Life Sciences, Genetics, Immunology +14

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma

Elena Pontarini, William Murray‐Brown, Cristina Croia et al. · Annals of the Rheumatic Diseases · 2020 · 183 citations · Full text

Life Sciences, Immunology, Pathology +17

Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III

Liliane Fossati‐Jimack, Andreea Ioan‐Facsinay, Luc Reininger et al. · The Journal of Experimental Medicine · 2000 · 180 citations

Life Sciences, Immunology, Pathology +17